EW vs TDG · P/E 47, rev $3.39B vs P/E 41, rev $8.83B
Edwards Lifesciences Corp (EW) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
EW currently screens at market cap $49.91B and trailing P/E 46.9. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the EW and TDG stock pages for the full models.
Not investment advice.